GLP-1 and NMDA Targeted Weight-Loss Drug Shows Promise
A new "Trojan Horse" weight-loss drug combines GLP-1 and NMDA receptor blockers to target the brain's appetite control center. Promising results in mice could lead to a revolutionary treatment for obesity.
Source:
About Neuroscience News
Official Neuroscience News Twitter. Brain research news articles on neuroscience, psychology, AI, neurology, brain cancer, robotics, mental health & science.